When alliances fail, is arbitration the answer?
The global pandemic has increased collaboration and a new wave of disputes is likely. Arbitration is well placed to help, argue Kate Davies McGill, Gaela Gehring Flores and Paul Keller of Allen & Overy
- Amendments to Chinese Patents Law for the Life Sciences 09-09-2021
- COVID-19: Protection of IP for AI tools 01-09-2020
- Agri-patents: The battle of the seeds 20-05-2019
- Conference preview: ChinaBio Partnering Forum 2019 07-05-2019
- A patent attack on three fronts 02-10-2018
Latest asia news
Texas court awards $41m to US biotech
21-07-2022
Japan-based pharma company must pay for infringment | Drug was recently approved for breast cancer treatment by EU.
